Lantheus Holdings, Inc. Deferred Revenue Recognized
Lantheus Holdings, Inc. (LNTH) reported Deferred Revenue Recognized of -$3.23 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-06
- Lantheus Holdings, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was -$1.33M.
- Lantheus Holdings, Inc. contract with customer, liability, revenue recognized for the quarter ending 2019-03-31 was $8.00K, a 0.00% change year-over-year.
- Lantheus Holdings, Inc. contract with customer, liability, revenue recognized for the quarter ending 2018-09-30 was $8.00K.
- Lantheus Holdings, Inc. contract with customer, liability, revenue recognized for the quarter ending 2018-06-30 was $9.00K.
- Lantheus Holdings, Inc. contract with customer, liability, revenue recognized for fiscal 2025 was -$3.14M.
- Lantheus Holdings, Inc. contract with customer, liability, revenue recognized for fiscal 2024 was -$634.00K, a 192.96% decline from fiscal 2023.
- Lantheus Holdings, Inc. contract with customer, liability, revenue recognized for fiscal 2023 was $682.00K, a 179.51% increase from fiscal 2022.
- Lantheus Holdings, Inc. contract with customer, liability, revenue recognized for fiscal 2022 was $244.00K, a 639.39% increase from fiscal 2021.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month | Contract with Customer, Liability, Revenue Recognized 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$3.23M 10-Q · filed 2026-08-06 | ||||
| 2026-03-31 | -$1.33M 10-Q · filed 2026-05-07 | ||||
| 2025-12-31 | -$3.14M 10-K · filed 2026-02-26 | ||||
| 2024-12-31 | -$634.00K 10-K · filed 2026-02-26 | $447.00K 10-K · filed 2025-02-26 | |||
| 2023-12-31 | $682.00K 10-K · filed 2025-02-26 | ||||
| 2022-12-31 | $244.00K 10-K · filed 2024-02-22 | ||||
| 2021-12-31 | $33.00K 10-K · filed 2023-02-23 | ||||
| 2020-12-31 | $33.00K 10-K · filed 2022-02-24 | ||||
| 2019-12-31 | $33.00K 10-K · filed 2021-02-25 | ||||
| 2019-03-31 | $8.00K 10-Q · filed 2019-04-30 | ||||
| 2018-12-31 | $33.00K 10-K · filed 2020-02-25 | ||||
| 2018-09-30 | $8.00K 10-Q · filed 2018-10-30 | $25.00K 10-Q · filed 2018-10-30 | |||
| 2018-06-30 | $9.00K 10-Q · filed 2018-08-01 | $17.00K 10-Q · filed 2018-08-01 | |||
| 2018-03-31 | $8.00K 10-Q · filed 2019-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |